UCFA
VIRX

United Capital Financial Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

United Capital Financial Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,995
Closed -$860 – 1130
2025
Q1 		$860 Hold
42,995
– – ﹤0.01% 1054
2024
Q4 		$6.88K Hold
42,995
– – ﹤0.01% 1051
2024
Q3 		$9.89K Buy
+42,995
New +$9.89K ﹤0.01% 1052